Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.

We have recently shown that non-viral gene therapy can stabilise the decline of lung function in patients with cystic fibrosis (CF). However, the effect was modest, and more potent gene transfer agents are still required. Fuson protein (F)/Hemagglutinin/Neuraminidase protein (HN)-pseudotyped lentivi...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Alton, E, Beekman, J, Boyd, A, Brand, J, Carlon, M, Connolly, M, Chan, M, Conlon, S, Davidson, H, Davies, J, Davies, L, Dekkers, J, Doherty, A, Gea-Sorli, S, Gill, D, Griesenbach, U, Hasegawa, M, Higgins, T, Hironaka, T, Hyndman, L, McLachlan, G, Inoue, M, Hyde, S, Innes, J, Maher, T, Moran, C, Meng, C, Paul-Smith, M, Pringle, I, Pytel, K, Rodriguez-Martinez, A, Schmidt, A, Stevenson, B, Sumner-Jones, S, Toshner, R, Tsugumine, S, Wasowicz, M, Zhu, J
פורמט:	Journal article
שפה:	English
יצא לאור:	BMJ Publishing Group 2016

פריטים דומים

Preparation for a first-in-man lentivirus trial in cystic fibrosis patients
מאת: Griesenbach, U, et al.
יצא לאור: (2016)

Moving lentiviral-based gene therapy into a first-in-man CF trial
מאת: Griesenbach, D, et al.
יצא לאור: (2015)

Towards a first-in-human trial with a pseudotyped lentivirus
מאת: Alton, EW, et al.
יצא לאור: (2020)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
מאת: Hyde, S, et al.
יצא לאור: (2015)

Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.
מאת: Griesenbach, U, et al.
יצא לאור: (2012)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS AS A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
מאת: Griesenbach, U, et al.
יצא לאור: (2012)

ASSESSMENT OF F/HN-PSEUDOTYPED LENTIVIRUS IN A CLINICALLY RELEVANT VECTOR FOR LUNG GENE THERAPY
מאת: Griesenbach, U, et al.
יצא לאור: (2012)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
מאת: Alton, E, et al.
יצא לאור: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
מאת: Alton, E, et al.
יצא לאור: (2014)

Lentivirus gene therapy for autoimmune pulmonary alveolar proteinosis
מאת: Palau, H, et al.
יצא לאור: (2019)

The lung as a factory to produce secreted intrapulmonary and circulatory proteins
מאת: Paul-Smith, M, et al.
יצא לאור: (2017)

Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
מאת: Alton, E, et al.
יצא לאור: (2012)

REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES
מאת: Alton, E, et al.
יצא לאור: (2012)

Lentivirus GM-CSF gene therapy for autoimmune pulmonary alveolar proteinosis
מאת: Lund-Palau, H, et al.
יצא לאור: (2018)

The murine lung as a factory to produce secreted intrapulmonary and circulatory proteins
מאת: Paul-Smith, M, et al.
יצא לאור: (2018)

Lentivirus GM-CSF gene therapy ameliorates autoimmune pulmonary alveolar proteinosis
מאת: Lund-Palau, H, et al.
יצא לאור: (2018)

Recombinant Sendai virus vector to evaluate vector distribution in a large animal model of lung gene transfer
מאת: McLachlan, G, et al.
יצא לאור: (2004)

Pre-existing immunity to human parainfluenza virus (hPIV) does not affect rSIV.F/HN-mediated transduction efficiency
מאת: Pytel, K, et al.
יצא לאור: (2016)

Development of an immunocytochemical assay to detect human CFTR expression following gene therapy
מאת: Davidson, H, et al.
יצא לאור: (2008)

Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.
מאת: McLachlan, G, et al.
יצא לאור: (2011)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
מאת: Griesenbach, U, et al.
יצא לאור: (2011)

Caprine lentivirus in sheep milk and semen
מאת: C.C.V. Lima, et al.

An immunocytochemical assay to detect human CFTR expression following gene transfer.
מאת: Davidson, H, et al.
יצא לאור: (2009)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
מאת: Sergijenko, A, et al.
יצא לאור: (2020)

Genetic medicines for CF: Hype versus reality
מאת: Alton, E, et al.
יצא לאור: (2016)

A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution.
מאת: Gifford, R, et al.
יצא לאור: (2008)

OPTIMISATION OF MOLECULAR ASSAYS FOR CLINICAL TRIAL OF GL67A/PDNA DELIVERY TO NOSE AND LUNG OF CF PATIENTS
מאת: Sumner-Jones, S, et al.
יצא לאור: (2009)

Gene therapy for respiratory diseases; progress and a changing context
מאת: Alton, EWFW, et al.
יצא לאור: (2020)

DEVELOPMENT, PRODUCTION AND EVALUATION OF CLINICAL GRADE CFTR EXPRESSION PLASMID FOR CF LUNG GENE THERAPY
מאת: Gill, DR, et al.
יצא לאור: (2010)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep
מאת: Alton, E, et al.
יצא לאור: (2013)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.
מאת: Alton, E, et al.
יצא לאור: (2013)

Discovery and analysis of the first endogenous lentivirus
מאת: Katzourakis, A, et al.
יצא לאור: (2007)

Discovery and analysis of the first endogenous lentivirus.
מאת: Katzourakis, A, et al.
יצא לאור: (2007)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CYSTIC FIBROSIS: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY''
מאת: Davies, J, et al.
יצא לאור: (2009)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CF: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY"
מאת: Davies, J, et al.
יצא לאור: (2009)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
מאת: Davies, G, et al.
יצא לאור: (2011)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF
מאת: Davies, J, et al.
יצא לאור: (2011)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis
מאת: Alton, E, et al.
יצא לאור: (2013)

Update on the UK CF Gene Therapy Consortium Multidoes, non-viral, gene therapy trial
מאת: Alton, E, et al.
יצא לאור: (2012)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.
מאת: Alton, E, et al.
יצא לאור: (2013)